uniQure N.V.uniQure N.V.uniQure N.V.

uniQure N.V.

No trades
See on Supercharts
Market capitalization
‪226.75 M‬USD
−6.47USD
‪−308.48 M‬USD
‪15.84 M‬USD
‪42.55 M‬
Beta (1Y)
2.13

About uniQure N.V.

CEO
Matthew C. Kapusta
Headquarters
Amsterdam
Employees (FY)
480
Founded
2012
ISIN
NL0010696654
FIGI
BBG005SSJYH3
uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, the Netherlands.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of QURE is 4.75 USD — it has increased by 0.11% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange uniQure N.V. stocks are traded under the ticker QURE.
uniQure N.V. is going to release the next earnings report on Apr 29, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for uniQure N.V. has a max estimate of 30.00 USD and a min estimate of 7.00 USD.
QURE earnings for the last quarter are −1.88 USD whereas the estimation was −0.85 USD which accounts for −120.00% surprise. Estimated earnings for the next quarter are −1.46 USD. See more details about uniQure N.V. earnings.
uniQure N.V. revenue for the last quarter amounts to ‪1.41 M‬ USD despite the estimated figure of ‪29.49 M‬ USD. In the next quarter revenue is expected to reach ‪5.60 M‬ USD.
Yes, you can track uniQure N.V. financials in yearly and quarterly reports right on TradingView.
Like other stocks, QURE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade uniQure N.V. stock right from TradingView charts — choose your broker and connect to your account.
QURE reached its all-time high on Jun 20, 2019 with the price of 82.49 USD, and its all-time low was 4.72 USD and was reached on May 8, 2017.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 480.00 employees. See our rating of the largest employees — is uniQure N.V. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. uniQure N.V. EBITDA is ‪−208.08 M‬ USD, and current EBITDA margin is ‪−1.64 K‬%. See more stats in uniQure N.V. financial statements.